Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

762
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

341
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

2.2K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
2.2K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.6K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

38
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[ENZYME THERAPY OF POSTCHOLECYSTECTOMY SYNDROME IN CHILDREN].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2015
Same author

[The evolution of understanding the concept of biliary tract diseases in childhood].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2014
Same author

[Dyslipidemia in children with cholelithiasis as a marker of metabolic syndrome development].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2014
Same author

[The treatment of gallbladder cholesterosis in children].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2014
Same author

[The study of hormonal status in children with gastroesophageal reflux disease].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2014
Same author

[Modern aspects of the prevention of diseases of the digestive system in children ].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology·2013

Related Experiment Video

Updated: Apr 5, 2026

Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.6K

[PEDIATRIC GASTROENTEROLOGY: ORIGINS, PROBLEMS, AND PROSPECTS OF THE RESEARCH].

A M Zaprudnov, L A Kharitonova, K I Grigoriev

    Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology
    |August 19, 2015
    PubMed
    Summary

    Pediatric gastroenterology faces new challenges with emerging digestive diseases in children, including gastroesophageal reflux disease and Crohn's disease. Early diagnosis and management are crucial for preventing long-term health issues and disability.

    More Related Videos

    Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
    10:15

    Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

    Published on: March 22, 2017

    7.4K
    Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
    06:51

    Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

    Published on: July 28, 2023

    1.9K

    Related Experiment Videos

    Last Updated: Apr 5, 2026

    Tissue Engineering of the Intestine in a Murine Model
    08:45

    Tissue Engineering of the Intestine in a Murine Model

    Published on: December 1, 2012

    15.6K
    Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
    10:15

    Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

    Published on: March 22, 2017

    7.4K
    Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
    06:51

    Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

    Published on: July 28, 2023

    1.9K

    Area of Science:

    • Pediatric Gastroenterology
    • Digestive System Diseases in Children
    • Clinical and Social Pediatrics

    Context:

    • The nomenclature of pediatric digestive diseases has expanded to include conditions like gastroesophageal reflux disease (GERD), peptic ulcer disease, Crohn's disease, and celiac disease.
    • Modern children exhibit unique features of gastrointestinal diseases, including allergic predispositions, neuro-autonomic and psycho-emotional changes, and polymorbidity.
    • There is a concerning trend of "rejuvenation," where adult-typical digestive diseases like cholelithiasis and Crohn's disease are increasingly diagnosed in children.

    Purpose:

    • To outline the evolving landscape of digestive diseases in pediatric populations.
    • To highlight the specific characteristics and challenges associated with childhood gastroenterological conditions.
    • To underscore the clinical and social significance of these diseases in early life.

    Summary:

    • New and existing digestive diseases are presenting with unique features in children, influenced by environmental and lifestyle factors.
    • Key conditions include GERD, peptic ulcer disease, Crohn's disease, and celiac disease, often occurring with polymorbidity.
    • Adverse outcomes such as chronicity, complications, and disability risk are significant concerns, alongside the high cost of advanced treatments.

    Impact:

    • Early manifestation of diseases like peptic ulcer disease and Crohn's disease significantly impacts children's quality of life and places a burden on families.
    • The origins of many adult digestive diseases are rooted in childhood, emphasizing the importance of pediatric gastroenterological care.
    • Addressing these challenges is critical for applied and scientific pediatric gastroenterology, necessitating effective medical and prophylactic strategies.